South Korea
Novo Nordisk is bringing its expertise in chronic disease management to Kakao's mobile diabetes app.
Also, AIM will be collaborating with Stanford Medicine to validate its diagnostic endoscopic AI.
Also, Fujifilm is reorganising its Medical Systems business units.
Also, Augnito unveils its ambient technology for clinical documentation.
i-SENS is also seeking CE certification for its CGM product in Europe.
The CGM-based service will begin in Q4.
Also, South Korean researchers have built an AI model for predicting the side effects of immunotherapy on a patient.
Also, Vuno is developing health content for chronic disease patients on Hativ Care.
It has partnered with Capio S:t Göran Hospital to help analyse 78,000 breast images each year.
It is a simple and low-cost model that promotes the early detection of the condition.